Niagen Bioscience Inc (FRA:OCD1)
€ 2.58 (0%) Market Cap: 230.49 Mil Enterprise Value: 174.35 Mil PE Ratio: 15.67 PB Ratio: 3.18 GF Score: 67/100

Q1 2026 Niagen Bioscience Inc Earnings Call Transcript

May 6, 2026 / 08:30 PM GMT
Release Date Price: €4.26 (+7.04%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NAGE.OQ - Niagen Bioscience Inc
Q1 2026 Niagen Bioscience Inc Earnings Call
May 06, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for standing by and welcome to Niagen Bioscience Inc.'s first quarter 2026 earnings conference call. My name is Karina and I will be the conference operator today.

At this time, all participants are in a listen-only mode. As a reminder, this conference call is being recorded. Earlier today, Niagen Bioscience issued a press release announcing its financial results for the first quarter of 2026.

If you have not reviewed this information, it is available within the Investor Relations section of Niagen Bioscience's website at www.niagenbioscience.com.

I would now like to turn the call over to Lauren Burzanski, Assistant Controller. Please go ahead.

-------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot